These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24556147)

  • 1. Novel 8-(p-substituted-phenyl/benzyl)xanthines with selectivity for the A2A adenosine receptor possess bronchospasmolytic activity.
    Yadav R; Bansal R; Kachler S; Klotz KN
    Eur J Med Chem; 2014 Mar; 75():327-35. PubMed ID: 24556147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchospasmolytic activity and adenosine receptor binding of some newer 1,3-dipropyl-8-phenyl substituted xanthine derivatives.
    Gumber D; Yadav D; Yadav R; Kachler S; Klotz KN
    Chem Biol Drug Des; 2020 Jun; 95(6):600-609. PubMed ID: 32100461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological characterization of novel xanthine carboxylate amides as A2A adenosine receptor ligands exhibiting bronchospasmolytic activity.
    Yadav R; Bansal R; Rohilla S; Kachler S; Klotz KN
    Bioorg Chem; 2016 Apr; 65():26-37. PubMed ID: 26851736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a series of 8-(substituted-phenyl)xanthines and a study on the effects of substitution pattern of phenyl substituents on affinity for adenosine A(1) and A(2A) receptors.
    Bansal R; Kumar G; Gandhi D; Young LC; Harvey AL
    Eur J Med Chem; 2009 May; 44(5):2122-7. PubMed ID: 19036477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of a New Series of 8-(2-Nitroaryl)Xanthines as Adenosine Receptor Ligands.
    Bansal R; Kumar G; Rohilla S; Klotz KN; Kachler S; Young LC; Harvey AL
    Drug Dev Res; 2016 Aug; 77(5):241-50. PubMed ID: 27404511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
    Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
    Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships in a series of 8-substituted xanthines as bronchodilator and A1-adenosine receptor antagonists.
    Corsano S; Strappaghetti G; Scapicchi R; Lucacchini A; Senatore G
    Arch Pharm (Weinheim); 1995 Sep; 328(9):654-8. PubMed ID: 7487422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.
    Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J
    J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a new series of 1H-imidazol-1-yl substituted 8-phenylxanthines as adenosine receptor ligands.
    Bansal R; Kumar G; Gandhi D; Young LC; Harvey AL
    Chem Biodivers; 2011 Jul; 8(7):1290-300. PubMed ID: 21766450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchospasmolytic and Adenosine Binding Activity of 8- (Proline / Pyrazole)- Substituted Xanthine Derivatives.
    Singh S; Ojha M; Yadav D; Kachler S; Klotz KN; Yadav R
    Curr Drug Discov Technol; 2021; 18(5):e22092020186181. PubMed ID: 32962622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists.
    Rodríguez-Borges JE; García-Mera X; Balo MC; Brea J; Caamaño O; Fernández F; López C; Loza MI; Nieto MI
    Bioorg Med Chem; 2010 Mar; 18(5):2001-9. PubMed ID: 20137957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
    Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
    Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and preliminary evaluation of new 1- and 3-[1-(2-hydroxy-3-phenoxypropyl)]xanthines from 2-amino-2-oxazolines as potential A1 and A2A adenosine receptor antagonists.
    Massip S; Guillon J; Bertarelli D; Bosc JJ; Léger JM; Lacher S; Bontemps C; Dupont T; Müller CE; Jarry C
    Bioorg Med Chem; 2006 Apr; 14(8):2697-719. PubMed ID: 16386423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A
    Rohilla S; Bansal R; Kachler S; Klotz KN
    Bioorg Chem; 2019 Jun; 87():601-612. PubMed ID: 30933785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 8-(cyclopentyloxy)phenyl substituted xanthine derivatives as adenosine A2A ligands.
    Bansal R; Kumar G; Gandhi D; Yadav R; Young LC; Harvey AL
    Arzneimittelforschung; 2010; 60(3):131-6. PubMed ID: 20422944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilator activity of xanthine derivatives substituted with functional groups at the 1- or 7-position.
    Miyamoto K; Yamamoto Y; Kurita M; Sakai R; Konno K; Sanae F; Ohshima T; Takagi K; Hasegawa T; Iwasaki N
    J Med Chem; 1993 May; 36(10):1380-6. PubMed ID: 8496906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structure-activity relationships of bronchospasmolytic beta-phenylethyl-aminoalkyl-xanthines (author's transl)].
    Habersang S; Klingler KH; Schlichtegroll A
    Arzneimittelforschung; 1977; 27(12):14-21. PubMed ID: 576827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor.
    Carotti A; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Stefanachi A; Vidal B
    J Med Chem; 2006 Jan; 49(1):282-99. PubMed ID: 16392813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.
    Koch P; Akkari R; Brunschweiger A; Borrmann T; Schlenk M; Küppers P; Köse M; Radjainia H; Hockemeyer J; Drabczyńska A; Kieć-Kononowicz K; Müller CE
    Bioorg Med Chem; 2013 Dec; 21(23):7435-52. PubMed ID: 24139167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.